UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

IL-17: A Key Player in the P. acnes Inflammatory Cascade?

Journal of investigative dermatology, 2014-02, Vol.134 (2), p.307-310

2014

Volltextzugriff (PDF)

An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains

PloS one, 2012-07, Vol.7 (7), p.e41480-e41480

2012

Volltextzugriff (PDF)

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections

Current opinion in infectious diseases, 2003-04, Vol.16 (2), p.103-124

2003

Volltextzugriff (PDF)

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

The Lancet (British edition), 2004-12, Vol.364 (9452), p.2188-2195

2004

Volltextzugriff (PDF)

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review

American journal of clinical dermatology, 2017-04, Vol.18 (2), p.169-191

2017

Volltextzugriff (PDF)

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

American journal of clinical dermatology, 2003, Vol.4 (12), p.813-831

2003

Volltextzugriff (PDF)

Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set

Journal of investigative dermatology, 2017-08, Vol.137 (8), p.1784-1786

2017

Volltextzugriff (PDF)

Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership

BMJ open, 2015-07, Vol.5 (7), p.e008085-e008085

2015

Volltextzugriff (PDF)

A Distinct Acne Microbiome: Fact or Fiction?

Journal of investigative dermatology, 2013-09, Vol.133 (9), p.2294-2295

2013

Volltextzugriff (PDF)

Minocycline for acne vulgaris: efficacy and safety

Cochrane database of systematic reviews, 2012-08 (8), p.CD002086

2012

Volltextzugriff (PDF)

A Honey Trap for the Treatment of Acne: Manipulating the Follicular Microenvironment to Control Propionibacterium acnes

BioMed research international, 2013-01, Vol.2013, p.679680-8

2013

Volltextzugriff (PDF)

16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium

Antimicrobial Agents and Chemotherapy, 1998-07, Vol.42 (7), p.1702-1705

1998

Volltextzugriff (PDF)

Prioritizing treatment outcomes: How people with acne vulgaris decide if their treatment is working

Journal of evidence-based medicine, 2017-08, Vol.10 (3), p.163-170

2017

Volltextzugriff (PDF)

Identifying the Impacts of Acne: A Delphi Survey of Patients and Clinicians

Journal of cutaneous medicine and surgery, 2020-05, Vol.24 (3), p.259-266

2020

Volltextzugriff (PDF)

Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review

American journal of clinical dermatology, 2021-03, Vol.22 (2), p.159-171

2021

Volltextzugriff (PDF)

Propionibacterium acnes in Human Health and Disease

BioMed research international, 2013-01, Vol.2013, p.493564-3

2013

Volltextzugriff (PDF)

Detection of transposon Tn5432–mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities

Journal of antimicrobial chemotherapy, 2002-01, Vol.49 (1), p.165-168

2002

Volltextzugriff (PDF)

Stemming the tide of antimicrobial resistance: implications for management of acne vulgaris

British journal of general practice, 2018-02, Vol.68 (667), p.64-65

2018

Volltextzugriff (PDF)

Pro-inflammatory levels of interleukin-1α-like bioactivity are present in the majority of open comedones in acne vulgaris

Journal of investigative dermatology, 1992-06, Vol.98 (6), p.895-901

1992

Volltextzugriff (PDF)

Cochrane Review: Minocycline for acne vulgaris: efficacy and safety

Evidence-based child health, 2011-09, Vol.6 (5), p.1440-1544

2011

Volltextzugriff (PDF)

Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients

British journal of dermatology (1951), 1990-02, Vol.122 (2), p.233-244

1990

Volltextzugriff (PDF)

Multiple mechanisms of erythromycin resistance

Journal of antimicrobial chemotherapy, 1990-10, Vol.26 (4), p.461-465

1990

Volltextzugriff (PDF)

A variety of Gram-positive bacteria carry mobile mef genes

Journal of antimicrobial chemotherapy, 1999-07, Vol.44 (1), p.19-25

1999

Volltextzugriff (PDF)

Robust evidence is needed in treating acne

BMJ. British medical journal (International ed.), 2002-12, Vol.325 (7377), p.1422

International edition, 2002

Volltextzugriff (PDF)

Viewpoint 3

Experimental dermatology, 2005-02, Vol.14 (2), p.148-150

Eady, E. Anne

2005

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(44)
Humans
(41)
Dermatology
(21)
Biological And Medical Sciences
(20)
Acne Vulgaris - Drug Therapy
(15)
Microbiology
(14)
Female
(13)
Medical Sciences
(13)
Acne
(12)
Acne Vulgaris - Microbiology
(12)
Adult
(12)
Male
(12)
Skin - Microbiology
(12)
Adolescent
(11)
Anti-Bacterial Agents - Therapeutic Use
(10)
Drug Resistance, Microbial
(10)
Infectious Diseases
(10)
Pharmacology & Pharmacy
(9)
Pharmacology. Drug Treatments
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

IL-17: A Key Player in the P. acnes Inflammatory Cascade?

An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections

Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial

Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

Identifying What to Measure in Acne Clinical Trials: First Steps towards Development of a Core Outcome Set

Identifying acne treatment uncertainties via a James Lind Alliance Priority Setting Partnership

A Distinct Acne Microbiome: Fact or Fiction?

Minocycline for acne vulgaris: efficacy and safety

A Honey Trap for the Treatment of Acne: Manipulating the Follicular Microenvironment to Control Propionibacterium acnes

16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium

Prioritizing treatment outcomes: How people with acne vulgaris decide if their treatment is working

Identifying the Impacts of Acne: A Delphi Survey of Patients and Clinicians

Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review

Propionibacterium acnes in Human Health and Disease

Detection of transposon Tn5432–mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities

Stemming the tide of antimicrobial resistance: implications for management of acne vulgaris

Pro-inflammatory levels of interleukin-1α-like bioactivity are present in the majority of open comedones in acne vulgaris

Cochrane Review: Minocycline for acne vulgaris: efficacy and safety

Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients

Multiple mechanisms of erythromycin resistance

A variety of Gram-positive bacteria carry mobile mef genes

Robust evidence is needed in treating acne

Viewpoint 3

Suchergebnisse filtern